Morphine oral - Purdue PharmaAlternative Names: V-113741
Latest Information Update: 23 Feb 2016
At a glance
- Originator Purdue Pharma
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 15 Mar 2016 Biomarkers information updated